Collectively, these data highlight a novel regulatory role of SLCO4A1-AS1 in c-Myc signalling via the Hsp90-Cdk2 axis in CRC, suggesting that SLCO4A1-AS1 represents a potential therapeutic target and prognostic factor for CRC. This evidence concerns the gene SLCO4A1 and colorectal carcinoma.